Goleta breast implant manufacturer Sientra wrapped up a tumultuous year with revenue gains, but missed earnings estimates and continued to burn through cash as it ramped up sales of new products and awaited manufacturing approval. Sientra reported $11.1 million in fourth quarter revenues, for total net sales of $36.5 million in 2017, up 76 percent…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
